Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001493152-24-036474
Filing Date
2024-09-17
Accepted
2024-09-17 06:36:15
Documents
5

Document Format Files

Seq Description Document Type Size
1 form424b4.htm 424B4 2506539
2 logo_003.jpg GRAPHIC 4863
3 chart_002.jpg GRAPHIC 220685
4 chart_022.jpg GRAPHIC 273662
5 logo_001.jpg GRAPHIC 3581
  Complete submission text file 0001493152-24-036474.txt   3200467
Mailing Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064
Business Address 2355 WESTWOOD BLVD. #139 LOS ANGELES CA 90064 818-404-5541
Kairos Pharma, LTD. (Filer) CIK: 0001962011 (see all company filings)

EIN.: 462993314 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-274805 | Film No.: 241302547
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)